TCR2 Therapeutics’ $125 Million Series B Financing

Goodwin advised TCR2 Therapeutics on the completion of its highly oversubscribed $125 million Series B financing round. Proceeds of the financing will be used to advance…

This content is for members only.
Login to Read More Join Now

PrintFriendly

OncoC4’s Strategic Collaboration with BioNTech

American International Group’s $750 Million Notes Offering

Arcade Beauty’s Out-Of-Court Restructuring

Leasy Peru’s $25 Million Financing

Credito Directo’s $2,4 Million Notes Offering

Banijay Americas’ Acquisition of Majority Stake in Studio A Fábrica

Aleph Group’s Majority Stake Acquisition in Clever PPC

Voltalis’ EUR 91 Million Secured Financing

IMAXXAM’s Acquisition of Office Portfolio

National Paints’ Raising Bid for Pachin

Hasan Allam Utilities’ Joint Venture with Agility to Establish YANMU

Nogoom Football Club v. Ismaili Sporting Club

APY Ventures’ Investment in Turan

Bank of Sharjah’s US$500 Million Notes Offering

Medicover’s Acquisition of Guven Lab

Anglo American’s Maritime Transportation Strategy

Merricks Capital’s $465 Million Sindacate Facility

CBL International Limited’s $13.3 Million IPO

Russell McVeagh welcomes new Wellington-based Real Estate & Construction partner

TozziniFreire’s Restructuring and Insolvency Practice adds a New Partner

Cooley Announces New Leadership in Asia

Personal data transfers to the United States: latest news

The national procedure on the subject of ‘Golden Power’ is split in two-phases: clarifications by the Italian Council of State

Deductibility of “Blacklist” costs in Italy: the 2023 Budget Law (re)introduced new limitations

Russell McVeagh welcomes new Wellington-based Real Estate & Construction partner

TozziniFreire’s Restructuring and Insolvency Practice adds a New Partner

Clark Hill Adds Ari Derman to Banking and Financial Services Practice

TCR2 Therapeutics’ $125 Million Series B Financing

Author: Ambrogio Visconti